Jennison Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-695,019
Closed -$49.5M 586
2026
Q1
$49.5M Buy
695,019
+111,434
+19% +$8.79M 0.03% 222
2025
Q4
$47.9M Sell
583,585
-891,362
-60% -$69.5M 0.03% 211
2025
Q3
$111M Buy
1,474,947
+780,471
+112% +$58.2M 0.06% 125
2025
Q2
$51.4M Sell
694,476
-795,717
-53% -$55.4M 0.03% 213
2025
Q1
$120M Sell
1,490,193
-219,442
-13% -$18.9M 0.08% 120
2024
Q4
$134M Buy
1,709,635
+948,017
+124% +$80.6M 0.08% 112
2024
Q3
$71.5M Buy
761,618
+274,657
+56% +$23.1M 0.04% 169
2024
Q2
$37.9M Sell
486,961
-207,389
-30% -$16.9M 0.02% 256
2024
Q1
$63.1M Sell
694,350
-514,480
-43% -$42.8M 0.04% 180
2023
Q4
$93.5M Buy
1,208,830
+399,961
+49% +$28M 0.07% 119
2023
Q3
$55M Buy
808,869
+61,643
+8% +$4.48M 0.05% 163
2023
Q2
$60.7M Buy
747,226
+238,403
+47% +$19M 0.05% 164
2023
Q1
$41.7M Buy
+508,823
New +$36.3M 0.04% 210

Other funds holding GEHC

Jennison Associates's GEHC Position: Q2 2026 in Review

Jennison Associates sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 695,019 shares — an estimated $49.5M sold.

Jennison Associates first reported a position in GEHC in Q1 2023 and held it in 13 quarters. The position peaked at $134M in Q4 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Jennison Associates reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Jennison Associates sold 695,019 GE HealthCare shares in Q2 2026, an estimated $49.5M.
  • Jennison Associates first reported a position in GE HealthCare in Q1 2023 and held it in 13 quarters.
  • Jennison Associates's GE HealthCare position peaked at $134M in Q4 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.